Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets for the Treatment of Cystinuria

Ads

You May Also Like

TESARO Announces First-Quarter 2018 Operating Results

ZEJULA Q1 net sales totaled $49 millionEnrollment completed in Phase 3 PRIMA first-line ovarian ...

AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates

Positive Phase 2a Proof-of-Concept Data Reported from ANB020 Trials in Atopic Dermatitisand Peanut Allergy ...